Epidemiology of Non-Alcoholic Fatty Liver Disease

被引:684
作者
Bellentani, Stefano [1 ]
Scaglioni, Federica [1 ]
Marino, Mariano [1 ]
Bedogni, Giorgio [1 ,2 ]
机构
[1] Azienda USL Modena, Ctr Studi Fegato, Carpi, Italy
[2] Ctr Studi Fegato, Trieste, Italy
关键词
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Epidemiology; HEPATIC STEATOSIS; METABOLIC SYNDROME; NATURAL-HISTORY; RISK-FACTORS; TRANSAMINASE ABNORMALITIES; HEPATOCELLULAR-CARCINOMA; INDEPENDENT PREDICTORS; INSULIN-RESISTANCE; CLINICAL-FEATURES; STEATOHEPATITIS;
D O I
10.1159/000282080
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20-30%. About 2-3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the prevalence of NAFLD is higher in males and increases with increasing age, and it is influenced by the diagnostic method and the characteristics of the population, especially lifestyle habits. Population-based studies provide better estimates of the prevalence of NAFLD as compared to autoptic and clinical studies, but few such studies have been performed to date. The diagnosis of NAFLD in population studies is usually obtained by ultrasonography, which is known to underestimate the prevalence of fatty liver. The Dallas Heart Study and the Dionysos Study reported that 30% of the adults in the USA and 25% in Italy have NAFLD. In these studies, 79% and 55% of patients with NAFLD had normal aminotransferase levels, showing that liver enzymes are not surrogate markers of NAFLD in the general population. Noninvasive markers such as the fatty liver index obtained from the Dionysos Study may be useful to screen for NAFLD in the general population. The most important risk factors for NAFLD are male gender, age, obesity, insulin resistance and the cardiometabolic alterations that define the metabolic syndrome. The prevalence of NAFLD is 80-90% in obese adults, 30-50% in patients with diabetes and up to 90% in patients with hyperlipidemia. The prevalence of NAFLD among children is 3-10%, rising up to 40-70% among obese children. Moreover, pediatric NAFLD increased from about 3% a decade ago to 5% today, with a male-to-female ratio of 2:1. The incidence and natural history of NAFLD are still not well defined, but it is recognized that the majority of individuals with NAFLD do not develop NASH. The incidence of NAFLD is probably increasing in Western countries, strictly linked to lifestyle habits. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:155 / 161
页数:7
相关论文
共 75 条
  • [1] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [2] ALKHOURI N, 2009, GASTROENTEROL HEPATO, V3, P445
  • [3] Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
    Angulo, P
    Keach, JC
    Batts, KP
    Lindor, KD
    [J]. HEPATOLOGY, 1999, 30 (06) : 1356 - 1362
  • [4] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [5] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [6] Araújo LMB, 1998, DIABETES METAB, V24, P458
  • [7] NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY
    BACON, BR
    FARAHVASH, MJ
    JANNEY, CG
    NEUSCHWANDERTETRI, BA
    [J]. GASTROENTEROLOGY, 1994, 107 (04) : 1103 - 1109
  • [8] Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
    Bedogni, G
    Miglioli, L
    Masutti, F
    Tiribelli, C
    Marchesini, G
    Bellentani, S
    [J]. HEPATOLOGY, 2005, 42 (01) : 44 - 52
  • [9] Incidence and natural course of fatty liver in the general population: the dionysos study
    Bedogni, Giorgio
    Miglioli, Lucia
    Masutti, Flora
    Castiglione, Anna
    Croce, Lory Saveria
    Tiribelli, Claudio
    Bellentani, Stefano
    [J]. HEPATOLOGY, 2007, 46 (05) : 1387 - 1391
  • [10] The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
    Bedogni, Giorgio
    Bellentani, Stefano
    Miglioli, Lucia
    Masutti, Flora
    Passalacqua, Marilena
    Castiglione, Anna
    Tiribelli, Claudio
    [J]. BMC GASTROENTEROLOGY, 2006, 6 (1)